Concepts (246)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dengue | 17 | 2026 | 107 | 4.020 |
Why?
|
| HIV-1 | 10 | 2024 | 755 | 2.720 |
Why?
|
| Dengue Virus | 8 | 2025 | 96 | 2.550 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 8 | 2013 | 57 | 1.980 |
Why?
|
| Drug Resistance, Viral | 5 | 2024 | 67 | 1.860 |
Why?
|
| Simian immunodeficiency virus | 8 | 2013 | 60 | 1.740 |
Why?
|
| Puerto Rico | 34 | 2026 | 1413 | 1.660 |
Why?
|
| Morphine Dependence | 6 | 2010 | 23 | 1.570 |
Why?
|
| HIV Integrase Inhibitors | 2 | 2024 | 11 | 1.550 |
Why?
|
| Aedes | 5 | 2025 | 43 | 1.530 |
Why?
|
| HIV Infections | 7 | 2024 | 2586 | 1.320 |
Why?
|
| Arboviruses | 3 | 2025 | 8 | 1.190 |
Why?
|
| Chikungunya virus | 4 | 2024 | 18 | 1.050 |
Why?
|
| Viral Envelope Proteins | 3 | 2024 | 91 | 1.050 |
Why?
|
| Pyridones | 2 | 2024 | 50 | 1.000 |
Why?
|
| Antibodies, Viral | 8 | 2025 | 306 | 1.000 |
Why?
|
| Acquired Immunodeficiency Syndrome | 3 | 2021 | 226 | 0.900 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2025 | 47 | 0.890 |
Why?
|
| HIV Integrase | 1 | 2024 | 22 | 0.860 |
Why?
|
| Humans | 55 | 2026 | 43102 | 0.780 |
Why?
|
| Genotype | 5 | 2020 | 800 | 0.750 |
Why?
|
| Sequence Analysis, DNA | 5 | 2020 | 515 | 0.740 |
Why?
|
| Morphine | 3 | 2013 | 69 | 0.690 |
Why?
|
| Saliva | 2 | 2020 | 119 | 0.680 |
Why?
|
| Disease Progression | 6 | 2013 | 667 | 0.680 |
Why?
|
| Dengue Vaccines | 3 | 2024 | 16 | 0.610 |
Why?
|
| Child | 19 | 2026 | 3443 | 0.610 |
Why?
|
| Arbovirus Infections | 3 | 2025 | 6 | 0.610 |
Why?
|
| Executive Function | 1 | 2020 | 59 | 0.600 |
Why?
|
| Adult | 26 | 2026 | 13872 | 0.570 |
Why?
|
| Gene Products, env | 2 | 2009 | 23 | 0.570 |
Why?
|
| Mutation | 7 | 2023 | 1177 | 0.550 |
Why?
|
| Young Adult | 19 | 2026 | 5080 | 0.540 |
Why?
|
| Child, Preschool | 14 | 2026 | 1546 | 0.500 |
Why?
|
| Animals | 23 | 2025 | 16992 | 0.500 |
Why?
|
| Male | 29 | 2026 | 23409 | 0.490 |
Why?
|
| Evolution, Molecular | 4 | 2015 | 307 | 0.490 |
Why?
|
| Campylobacter jejuni | 6 | 2004 | 22 | 0.490 |
Why?
|
| Sensitivity and Specificity | 4 | 2025 | 611 | 0.470 |
Why?
|
| Bacteria | 1 | 2018 | 293 | 0.460 |
Why?
|
| Mental Disorders | 1 | 2020 | 392 | 0.450 |
Why?
|
| Female | 28 | 2026 | 24698 | 0.450 |
Why?
|
| Mosquito Control | 3 | 2025 | 15 | 0.450 |
Why?
|
| Immunoglobulin G | 3 | 2025 | 259 | 0.450 |
Why?
|
| Adolescent | 17 | 2026 | 6081 | 0.440 |
Why?
|
| Middle Aged | 19 | 2026 | 12222 | 0.430 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 609 | 0.430 |
Why?
|
| Inflammation | 1 | 2020 | 758 | 0.420 |
Why?
|
| Antigens, Bacterial | 5 | 2004 | 144 | 0.410 |
Why?
|
| Gene Products, vpr | 1 | 2013 | 5 | 0.410 |
Why?
|
| Wolbachia | 2 | 2025 | 4 | 0.410 |
Why?
|
| Glutamic Acid | 1 | 2014 | 131 | 0.400 |
Why?
|
| AIDS Dementia Complex | 1 | 2014 | 116 | 0.390 |
Why?
|
| Mutation, Missense | 1 | 2013 | 91 | 0.390 |
Why?
|
| Depression | 1 | 2020 | 863 | 0.370 |
Why?
|
| Virulence Factors | 1 | 2013 | 125 | 0.370 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2024 | 117 | 0.350 |
Why?
|
| Immunoglobulin M | 2 | 2022 | 86 | 0.350 |
Why?
|
| Influenza, Human | 2 | 2022 | 92 | 0.340 |
Why?
|
| Brain | 2 | 2009 | 1472 | 0.340 |
Why?
|
| Phylogeny | 4 | 2023 | 769 | 0.340 |
Why?
|
| Fever | 2 | 2022 | 62 | 0.340 |
Why?
|
| Opioid-Related Disorders | 2 | 2013 | 195 | 0.330 |
Why?
|
| Sentinel Surveillance | 3 | 2026 | 25 | 0.330 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2010 | 15 | 0.330 |
Why?
|
| Interleukin-18 | 1 | 2010 | 17 | 0.330 |
Why?
|
| Infant | 8 | 2026 | 1175 | 0.330 |
Why?
|
| Interleukin-12 | 1 | 2010 | 46 | 0.330 |
Why?
|
| Genetic Variation | 5 | 2020 | 430 | 0.330 |
Why?
|
| Macaca | 5 | 2009 | 36 | 0.320 |
Why?
|
| Aged | 13 | 2026 | 8214 | 0.310 |
Why?
|
| Retroviridae Proteins | 1 | 2009 | 7 | 0.300 |
Why?
|
| Cross-Sectional Studies | 5 | 2025 | 3156 | 0.300 |
Why?
|
| Hospitalization | 4 | 2026 | 485 | 0.290 |
Why?
|
| Polymorphism, Genetic | 2 | 2024 | 201 | 0.270 |
Why?
|
| Cohort Studies | 5 | 2023 | 1759 | 0.270 |
Why?
|
| Reassortant Viruses | 1 | 2006 | 11 | 0.250 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2024 | 458 | 0.250 |
Why?
|
| Bayes Theorem | 2 | 2025 | 126 | 0.240 |
Why?
|
| Disease Outbreaks | 2 | 2024 | 175 | 0.240 |
Why?
|
| Phenotype | 2 | 2024 | 780 | 0.240 |
Why?
|
| Macaca mulatta | 3 | 2013 | 139 | 0.240 |
Why?
|
| Cost of Illness | 1 | 2026 | 98 | 0.230 |
Why?
|
| Dominican Republic | 2 | 2023 | 20 | 0.230 |
Why?
|
| Health Care Costs | 1 | 2026 | 91 | 0.230 |
Why?
|
| Immune System | 2 | 2020 | 41 | 0.230 |
Why?
|
| Pest Control, Biological | 1 | 2025 | 9 | 0.230 |
Why?
|
| Serologic Tests | 2 | 2022 | 45 | 0.220 |
Why?
|
| Virus Diseases | 1 | 2025 | 27 | 0.220 |
Why?
|
| Respiratory Tract Infections | 1 | 2025 | 36 | 0.220 |
Why?
|
| Diketopiperazines | 1 | 2024 | 5 | 0.220 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2024 | 10 | 0.220 |
Why?
|
| Quinolones | 1 | 2024 | 14 | 0.220 |
Why?
|
| Oxazines | 1 | 2024 | 32 | 0.220 |
Why?
|
| Genomics | 2 | 2023 | 293 | 0.210 |
Why?
|
| Culicidae | 1 | 2023 | 26 | 0.210 |
Why?
|
| Piperazines | 1 | 2024 | 120 | 0.200 |
Why?
|
| Child Development | 1 | 2024 | 99 | 0.200 |
Why?
|
| Leukopenia | 1 | 2022 | 10 | 0.190 |
Why?
|
| Faculty | 1 | 2023 | 105 | 0.190 |
Why?
|
| Thrombocytopenia | 1 | 2022 | 23 | 0.190 |
Why?
|
| Astrocytes | 3 | 2013 | 244 | 0.190 |
Why?
|
| Social Environment | 1 | 2024 | 218 | 0.190 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2022 | 8 | 0.190 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2024 | 192 | 0.180 |
Why?
|
| Microcephaly | 1 | 2022 | 21 | 0.180 |
Why?
|
| Molecular Sequence Data | 4 | 2009 | 1542 | 0.180 |
Why?
|
| Peru | 1 | 2021 | 41 | 0.180 |
Why?
|
| Viruses | 1 | 2022 | 39 | 0.180 |
Why?
|
| Cyclonic Storms | 1 | 2023 | 80 | 0.180 |
Why?
|
| Prevalence | 3 | 2025 | 1612 | 0.180 |
Why?
|
| Vaccination | 4 | 2024 | 355 | 0.170 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2026 | 497 | 0.170 |
Why?
|
| Bile Acids and Salts | 1 | 2001 | 37 | 0.170 |
Why?
|
| Molecular Epidemiology | 2 | 2018 | 59 | 0.170 |
Why?
|
| Perception | 1 | 2022 | 215 | 0.170 |
Why?
|
| Laboratories | 1 | 2020 | 40 | 0.160 |
Why?
|
| Health Personnel | 1 | 2023 | 277 | 0.160 |
Why?
|
| Community Health Services | 1 | 2020 | 206 | 0.150 |
Why?
|
| Alcohol-Related Disorders | 1 | 2020 | 63 | 0.150 |
Why?
|
| Seroepidemiologic Studies | 3 | 2023 | 74 | 0.150 |
Why?
|
| Risk-Taking | 1 | 2021 | 457 | 0.140 |
Why?
|
| Mouth | 1 | 2018 | 54 | 0.140 |
Why?
|
| Bacterial Proteins | 3 | 2004 | 595 | 0.140 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2018 | 203 | 0.140 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2018 | 247 | 0.130 |
Why?
|
| Sexual Behavior | 1 | 2021 | 638 | 0.120 |
Why?
|
| ROC Curve | 2 | 2025 | 159 | 0.110 |
Why?
|
| Cytokines | 1 | 2018 | 678 | 0.110 |
Why?
|
| Disease Models, Animal | 3 | 2009 | 1596 | 0.110 |
Why?
|
| vpr Gene Products, Human Immunodeficiency Virus | 1 | 2013 | 8 | 0.100 |
Why?
|
| Chemokine CCL5 | 1 | 2013 | 41 | 0.100 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1070 | 0.100 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 98 | 0.100 |
Why?
|
| Survival Analysis | 1 | 2013 | 368 | 0.090 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 1 | 2012 | 59 | 0.090 |
Why?
|
| Memory Disorders | 1 | 2012 | 77 | 0.090 |
Why?
|
| Cross Reactions | 2 | 2022 | 87 | 0.090 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 2853 | 0.090 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2011 | 54 | 0.090 |
Why?
|
| Cell Line | 4 | 2024 | 1410 | 0.090 |
Why?
|
| Prospective Studies | 2 | 2025 | 1600 | 0.080 |
Why?
|
| Interleukin-6 | 1 | 2011 | 165 | 0.080 |
Why?
|
| Sequence Alignment | 2 | 2009 | 272 | 0.080 |
Why?
|
| Incidence | 2 | 2026 | 1078 | 0.080 |
Why?
|
| Genes, env | 1 | 2009 | 13 | 0.080 |
Why?
|
| Genes, Regulator | 1 | 2009 | 27 | 0.080 |
Why?
|
| Brain Chemistry | 1 | 2009 | 141 | 0.080 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 436 | 0.070 |
Why?
|
| Hippocampus | 1 | 2012 | 594 | 0.070 |
Why?
|
| Narcotics | 1 | 2008 | 29 | 0.070 |
Why?
|
| Primates | 1 | 2008 | 39 | 0.070 |
Why?
|
| NF-kappa B | 1 | 2011 | 358 | 0.070 |
Why?
|
| Amino Acid Sequence | 2 | 2009 | 1180 | 0.070 |
Why?
|
| HIV Reverse Transcriptase | 2 | 2020 | 35 | 0.070 |
Why?
|
| Oxidants | 1 | 2007 | 42 | 0.070 |
Why?
|
| Pregnancy | 2 | 2024 | 1772 | 0.070 |
Why?
|
| HIV | 1 | 2007 | 100 | 0.060 |
Why?
|
| Cells, Cultured | 3 | 2012 | 1621 | 0.060 |
Why?
|
| Semliki forest virus | 1 | 2024 | 1 | 0.060 |
Why?
|
| Vero Cells | 1 | 2024 | 112 | 0.050 |
Why?
|
| Neutralization Tests | 1 | 2024 | 57 | 0.050 |
Why?
|
| Seasons | 1 | 2025 | 139 | 0.050 |
Why?
|
| Antigens, Viral | 1 | 2024 | 48 | 0.050 |
Why?
|
| Age Distribution | 1 | 2024 | 249 | 0.050 |
Why?
|
| Flagella | 1 | 2004 | 32 | 0.050 |
Why?
|
| Antioxidants | 1 | 2007 | 443 | 0.050 |
Why?
|
| Education, Medical, Graduate | 1 | 2023 | 61 | 0.050 |
Why?
|
| Vaccines, Attenuated | 1 | 2023 | 75 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2024 | 306 | 0.050 |
Why?
|
| Dyspnea | 1 | 2022 | 22 | 0.050 |
Why?
|
| Cough | 1 | 2022 | 20 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2025 | 719 | 0.050 |
Why?
|
| Ambulatory Care Facilities | 1 | 2022 | 68 | 0.050 |
Why?
|
| Neurologic Examination | 1 | 2022 | 30 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2023 | 125 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2023 | 127 | 0.050 |
Why?
|
| Genome, Viral | 1 | 2022 | 119 | 0.050 |
Why?
|
| Transfection | 2 | 2013 | 532 | 0.050 |
Why?
|
| Campylobacter Infections | 1 | 2001 | 8 | 0.040 |
Why?
|
| Endemic Diseases | 1 | 2021 | 23 | 0.040 |
Why?
|
| Enteritis | 1 | 2001 | 6 | 0.040 |
Why?
|
| Communication | 1 | 2023 | 210 | 0.040 |
Why?
|
| Sexual Behavior, Animal | 1 | 2021 | 64 | 0.040 |
Why?
|
| Chloramphenicol | 1 | 2001 | 5 | 0.040 |
Why?
|
| Deoxycholic Acid | 1 | 2001 | 8 | 0.040 |
Why?
|
| Intention | 1 | 2022 | 108 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2007 | 1003 | 0.040 |
Why?
|
| Eukaryotic Cells | 1 | 2001 | 35 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 1063 | 0.040 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2021 | 53 | 0.040 |
Why?
|
| Bacterial Adhesion | 1 | 2001 | 41 | 0.040 |
Why?
|
| United States | 2 | 2022 | 5205 | 0.040 |
Why?
|
| Peptide Hydrolases | 1 | 2020 | 44 | 0.040 |
Why?
|
| Base Sequence | 1 | 2022 | 983 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2022 | 278 | 0.040 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2001 | 171 | 0.040 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2019 | 24 | 0.040 |
Why?
|
| Signal Transduction | 3 | 2013 | 2157 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2022 | 972 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 1081 | 0.040 |
Why?
|
| Genes, Bacterial | 1 | 1999 | 91 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 238 | 0.040 |
Why?
|
| Culture Media | 1 | 1999 | 96 | 0.040 |
Why?
|
| Serum Albumin, Bovine | 1 | 1999 | 49 | 0.040 |
Why?
|
| Parents | 1 | 2022 | 370 | 0.040 |
Why?
|
| Phagocytosis | 1 | 1999 | 86 | 0.040 |
Why?
|
| Age Factors | 1 | 2021 | 1154 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 440 | 0.030 |
Why?
|
| Sex Factors | 1 | 2021 | 1028 | 0.030 |
Why?
|
| Students | 1 | 2023 | 626 | 0.030 |
Why?
|
| Cattle | 1 | 1999 | 498 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2021 | 1604 | 0.030 |
Why?
|
| Risk Factors | 1 | 2022 | 3994 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2020 | 2544 | 0.030 |
Why?
|
| Brain Tissue Transplantation | 1 | 2012 | 4 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 652 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 209 | 0.020 |
Why?
|
| I-kappa B Proteins | 1 | 2011 | 36 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2012 | 95 | 0.020 |
Why?
|
| Fetus | 1 | 2011 | 101 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 934 | 0.020 |
Why?
|
| Motor Activity | 1 | 2012 | 437 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 1999 | 314 | 0.020 |
Why?
|
| Macrophages | 1 | 2012 | 529 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2012 | 1271 | 0.020 |
Why?
|
| Malondialdehyde | 1 | 2007 | 42 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2012 | 1766 | 0.020 |
Why?
|
| Catalase | 1 | 2007 | 110 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2007 | 201 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2007 | 158 | 0.020 |
Why?
|
| Viral Load | 1 | 2007 | 348 | 0.010 |
Why?
|
| Neurons | 1 | 2012 | 1263 | 0.010 |
Why?
|
| Anxiety | 1 | 2012 | 874 | 0.010 |
Why?
|
| Proton-Translocating ATPases | 1 | 2004 | 17 | 0.010 |
Why?
|
| Sigma Factor | 1 | 2004 | 19 | 0.010 |
Why?
|
| Virulence | 1 | 2004 | 246 | 0.010 |
Why?
|
| Foodborne Diseases | 1 | 2001 | 23 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 2001 | 134 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 1999 | 49 | 0.010 |
Why?
|
| Gene Library | 1 | 1999 | 62 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 1999 | 109 | 0.010 |
Why?
|
| Rabbits | 1 | 1999 | 278 | 0.010 |
Why?
|
| Plasmids | 1 | 1999 | 244 | 0.010 |
Why?
|
| Models, Biological | 1 | 2001 | 712 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1999 | 518 | 0.010 |
Why?
|